Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.64 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LSS | P48449 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | THRA | P10827 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3244613 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL15510986 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL1547511 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL9905921 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL1547966 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL12275607 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL5159543 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL10580100 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL116357 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A | |
| SCHEMBL9818095 | 1.00 | DNM1 (0.64) | DNM1THRBHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1748798-B1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | BAUSCH & LOMB (US) | 2010-05-05 | — | — | EP | claimed |
| US-20100113274-A1 | GLYPHOSATE FORMULATIONS CONTAINING AMIDOALKYLAMINE SURFACTANTS | MONSANTO TECHNOLOGY LLC (US) | 2010-05-06 | — | — | US | disclosed |
| EP-1748798-B1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | BAUSCH & LOMB (US) | 2010-05-05 | — | — | EP | disclosed |
| EP-0288515-B1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | ISP INVESTMENTS INC. (US) | 1993-05-05 | — | — | EP | disclosed |
| EP-0288515-A4 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | — | 1990-09-26 | — | — | EP | disclosed |
| EP-0288515-A1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS. | GAF CORP (US) | 1988-11-02 | — | — | EP | disclosed |
| WO-1988002985-A1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | GAF CORPORATION (US) | 1988-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113274-A1 | GLYPHOSATE FORMULATIONS CONTAINING AMIDOALKYLAMINE SURFACTANTS | GLRA3, GRHPR, GLRA1 | DNM1 2969/4885THRB 1257/4885HTT 1222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.